Parkinson's disease: A review

Frontiers in Bioscience - Scholar

Volumn 6 S, Issue 1, 2014, Pages 65-74

  Beitz, Janice M ^a  

^a Rutgers University Camden   (United States)

Author keywords

Dopaminergic therapy; Motor symptoms; Nonmotor symptoms; Parkinson's disease; Surgical therapy

Indexed keywords

MICRORNA;

ALTERNATIVE MEDICINE; AUTONOMIC DYSFUNCTION; BEHAVIOR CHANGE; BRADYKINESIA; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; COGNITIVE DEFECT; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENVIRONMENTAL STRESS; EXERCISE; EXPERIMENTAL THERAPY; FECES INCONTINENCE; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENE THERAPY; HIGH RISK PATIENT; HUMAN; INTEGUMENTARY SYSTEM; LEWY BODY; MOOD DISORDER; MUSCLE RIGIDITY; NEUROSURGERY; ONSET AGE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHYSIOTHERAPY; PREVALENCE; PSYCHOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEBORRHEA; SEXUAL DYSFUNCTION; SHUFFLING GAIT; SLEEP DISORDER; SPEECH THERAPY; SUBSTANTIA NIGRA PARS COMPACTA; SUPPORT GROUP; TREMOR; URINARY DYSFUNCTION; VISUAL HALLUCINATION; AGE; PATHOLOGY;

AGE FACTORS; HUMANS; PARKINSON DISEASE;

EID: 84897019904     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s415     Document Type: Review

References (63)

1. Sherer TB, S Chowdhury, K Peabody, D Brooks: Overcoming obstacles in Parkinson's Disease. Movement Disorders 27(13), 1606-1611 (2012)
2. Chou K: Clinical manifestations of Parkinson Disease. UpToDate. Retrieved on 7/22/2013 from www.uptodate.com. (2013)
3. Parkinson's Disease Foundation: Statistics on Parkinson's. Retrieved from http://www.pdf.org/en/parkinson-statistics. (2013)
4. Fritsch T, K Smyth, M Wallendal, T Hyde, G Leo, D Geldmacher: Parkinson Disease: Research update and clinical management. Southern Medical Association 105(12), 650-656 (2012)
5. Wright Willis A, B Evanoff, M Lian, S Criswell, B Racette: Geographic and ethnic variation in Parkinson Disease: A population-based study of US Medicare Beneficiaries. Neuroepidemiology, 34, 143-151 (2010)
6. Chinta S, C Lieu, M Demaria, R Laberge, J Campisi, J Anderson: Environmental stress, ageing, and glial cell senescence: A novel mechanistic link to Parkinson's Disease? Journal of Internal Medicine 273, 429-436 (2013)
7. MacPhee G, D Stewart: Parkinson's Disease. Reviews in Clinical Gerontology 11, 33-49 (2001)
8. Gazewood J, D Richards, K Clebak: Parkinson Disease: An update. American Family Physician 87(4), 267-273 (2013)
9. Brown T, P Rumsby, A Capleton, L Rushton, L Levy: Pesticides and Parkinson's Disease: Is there a link? Environmental Health Perspectives 14(2), 156-164 (2006)
10. Ceccatelli S: Mechanisms of neurotoxicity and implications for neurological disorders. Journal of Internal Medicine 273, 426-429 (2013)
11. Jankovic J, H Hurtig, J Dashe: Etiology and pathogenesis of Parkinson Disease. UpToDate. Retrieved on 7/22/2013 from www.uptodate.com. (2013)
12. Postuma R, J Gagnon, J Montplaisir: Clinical prediction of Parkinson's Disease: Planning for the age of neuroprotection. Journal of Neurology (81)9, 1008-1013 (2009)
13. Hawkes C, K Del Tredici, H Braak: Review: Parkinson's Disease: A dual-hit hypothesis. Neuropathology and Applied Neurobiology 33, 599-614 (2007)
14. Savica R, B Grossardt, J Bower, J Ahlskog, W Rocca: Risk factors for Parkinson's Disease may differ in men and women: An exploratory study. Hormones and Behavior 63, 308-314 (2013)
15. Chou K: Diagnosis of Parkinson Disease. UpToDate. Retrieved on 7/22/2013 from www.uptodate.com. (2013)
16. Shtilbans A, C Henchcliffe: Biomarkers in Parkinson's Disease: An update. Current Opinion of Neurology 25(4), 460-465 (2012)
17. Fahn S. Parkinson's Disease: 10 Years of progress, 1997-2007. Movement Disorders 25(Suppl 1), S2-S14 (2010)
18. Frank C, G Pari, J Rossiter: Approach to diagnosis of Parkinson Disease. Canadian Family Physician 52(7), 862-866 (2006)
19. Lew M. Overview of Parkinson's Disease. Pharmacotherapy 27(12 Pt 2), 155S-160S (2007)
20. Lim S, A Lang: The nonmotor symptoms of Parkinson's Disease-An overview. Movement Disorders 25(Suppl 1), S123-S130 (2010)
21. Jain S: Multi-organ autonomic dysfunction in Parkinson Disease. Parkinsonism and Related Disorders 17, 77-83 (2011)
22. Lohle M, A Storch, H Reichmann: Beyond tremor and rigidity: Non-motor features of Parkinson's Disease. Journal of Neural Transmission, 116, 1483-1492 (2009)
23. Aarsland D, M Beyer, M Kurz: Dementia in Parkinson's Disease. Current Opinion in Neurology 21, 676-682 (2088)
24. Politis M, K Wu, S Molloy: Parkinson's Disease symptoms: The patient's perspective. Movement Disorders 25, 1646 (2010)
25. Opara J, W Brola, M Leonardi, B Blaszcyk: Quality of life in Parkinson's Disease. Journal of Medicine and Life 5(4), 375-381 (2012)
26. Yeo L, R Singh, M Gundeti, J Barua, J Masood: Urinary tract dysfunction in Parkinson's Disease: A review. International Urology Nephrology, 44, 415-424 (2012)
27. Brandabur M: Recognizing and treating nonmotor aspects of Parkinson's Disease. Annals of Long-Term Care 15(8), 331-35 (2007)
28. Tarsy D. Management of comorbid problems associated with Parkinson Disease. UpToDate. Retrieved 7/22/2013 from http://www.uptodate.com/contents/ management-of-comorbid-problems-associated-with-pa
29. Chaplin H, J Hazan, P Wilson: Self-management for people with long-term neurological conditions. British Journal of Community Nursing 17(6), 250-257 (2012)
30. Beitz J: Skin and wound issues in patients with Parkinson's Disease: An overview of common disorders. Ostomy Wound Management 59(6), 26-36 (2013)
31. Djaldetti R, N Lev, E Melamed: Lesions outside the CNS in Parkinson's Disease. Movement Disorders 24(6), 793-800 (2009)
32. Constantinescu R, M Romer, K Kieburtz, the DATATOP Investigators of the Parkinson Study Group: Malignant melanoma in early Parkinson's disease. Movement Disorders 22(5), 720-722 (2007)
33. Ferreira J, D Neutel, T Mestre, M Coelho, M Rosa, O Rascol, C Sampaio: Skin cancer and Parkinson's Disease. Movement Disorders, 25(2), 139-148 (2010)
34. Ferreira J, R Katzenschlager, B Bloem, U Bonuccelli, D Burn, G Deuschl, E Dietrichs, G Fabbrini, A Friedman, P Kanovsky, V Kostic, A Nieuwboer, P Odin, W Poewe, O Rascol, C Sampaio, M Schupach, E Tolosa, C Trenkwalder, A Schapira, A Berardelli, W Oertel: Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's Disease. European Journal of Neurology 20, 5-15 (2013)
35. Fiala K, J Whetteckey, B Manyam: Malignant melanoma and levodopa in Parkinson's Disease: Causality or coincidence? Parkinsonism & Related Disorders 9, 321-327 (2003)
36. Fischer M, I Gemende, W Marsch, P Fischer: Skin function and skin disorders in Parkinson's Disease. Journal of Neural Transmission 108, 205-213 (2001)
37. Leibson C, D Maraganore, J Bower, J Ransom, P O'Brien, W Rocca: Comorbid conditions associated with Parkinson's Disease: A population-based study. Movement Disorders 21(4), 446-455 (2006)
38. Olsen J., K Tangerud, L Wermuth, K Frederiksen, S Friis: Treatment with Levodopa and risk for malignant melanoma. Movement Disorders 22(9), 1252-1257 (2007)
39. Pan T, X Li, J Jankovic: The association between Parkinson's disease and melanoma. International Journal of Cancer 128, 2251-2260 (2011)
40. Vermeij J, A Winogrodzka, J Trip, W Weber: Parkinson's disease, levodopa-use and the risk of melanoma. Parkinsonism and Related Disorders 15, 551-553 (2009)
41. Xu L, A Liu, H Kerr: Livedo reticular from amantadine. Skinmed, 9(5), 320-321 (2011)
42. Antonini A, L Bernardi, D Calandrella, F Mancini, M Plebani: Rotigotine transdermal patch in the management of Parkinson's Disease (PD) and its night-time use for PD-related sleep disorders. Functional Neurology 25(1), 21-25 (2010)
43. Perez-Lloret S, M Rey, P Ratti, O Rascol: Rotigotine transdermal patch for the treatment of Parkinson's Disease. Fundamental & Clinical Pharmacology 27, 81-95 (2012)
44. Watts R, J Jankovic, C Waters, A Rajput, B Boroojerdi, J Rao: Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson Disease. Neurology, 68, 272-276 (2007)
45. Dabby R, R Djaldetti, M Shahmurov, T Treves, B Gabai, E Melamed, M Sadeh, I Avinoach: Skin biopsy for assessment of autonomic denervation in Parkinson's Disease. Journal of Neural Transmission 113, 1169-1176 (2006)
46. Tarsy D: Nonpharmacologic management of Parkinson Disease. UpToDate. Retrieved 7/22/2013 from http://www.uptodate.com/contents/nonpharmacologic- management-of-parkinson-disease?... (2013)
47. LSVT: Rehabilitative therapy for people with Parkinson's Disease. http://www.lsvtglobal.com. Accessed 10/6/2013. (2013)
48. Ulamek-Koziol M, A Bogucka-Kocka, J Kocki, R Pluta: Editorial: Good and bad sides of diet in Parkinson's Disease. Nutrition, 29, 474-475 (2013)
49. Fuzhong L, P Harmer, K Fitzgerald, E Eckstrom, R Stock, J Galver, G Madalozzo, S Batya: Tai Chi and postural stability in patients with Parkinson's Disease. New England Journal of Medicine 366,511-519 (2012)
50. Wayne P: Tai Chi improves balance and motor control in Parkinson's Disease. Harvard Health Publications Retrieved 11/5/2013 from www.health.harvard.edu/blog/tai-chi-improves-balance-and-motor-control... (2013)
51. Berry A, T Foltynie: Gene therapy: A viable therapeutic strategy for Parkinson's Disease? Journal of Neurology, 258, 179-188 (2011)
52. Miyasaki J, W Martin, O Suchowersky, W Weiner, A Lang: Practice parameter: Initiation of treatment for Parkinson's Disease: An evidence-based review: Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 58(1), 11-17 (2002)
53. Cotton P, D Heisters: How to care for people with Parkinson's Disease. Nursing Times, 108(16), 12-14 (2012)
54. Agundez J, E Garcia-Martin, H Alonso-Navarro, F Jimenez-Jimenez: Anti-Parkinson's Disease drugs and pharmacogenetic considerations. Expert Opinion in Drug Metabolism and Toxicology 9(7), 859-874 (2013)
55. Suchowersky O, S Reich, J Perlmutter, T Zesiewicz, G Gronseth, W Weiner: Practice parameter diagnosis and prognosis of new onset Parkonson Disease (an evidence-based review) Report of the quality standards subcommittee of the American Academy of Neurology. Neurology, 66, 968-975 (2006)
56. Tarsy D: Motor fluctuations and dyskinesia in Parkinson Disease. UpToDate. Retrieved 7/22/2013 from http://www.uptodate.com/contents/motor- fluctuations-and-dyskinesia-in-parkinson's-disease... (2013)
57. Tarsy D: Pharmacologic treatment of Parkinson disease. UpToDate. Retrieved 7/22/2013 from http://www.uptodate.com/contents/pharmacologic- treatment-of-parkinson-disease?detecte... (2013)
58. Hauser R: Parkinson Disease. Medscape. Retrieved 10/28/2013 from http://emedicine.medscape.com/article/1831191-overview. (2013)
59. Loewenbruck K, A Storch: Stem cell-based therapies in Parkinson's Disease: Future hope or current treatment option? Journal of Neurology 258 (Suppl 2), S346-S353 (2011)
60. Rutten S, C Vriend, O van den Heuvel, J Smit, H Berendse., Y van der Werf: Bright light therapy in Parkinson's Disease: An overview of the background and evidence. Parkinson's Disease 767105. Doi: 10:1155/2012/767105. 9 pgs. (2012)
61. Bjorklund A, J Kordower:. Cell therapy for Parkinson's Disease: What next? Movement Disorder 28(1), 110-115 (2013)
62. Tenenbaum L, A Chtarto, E Lehtonen, D Blum, V Baekelandt, T Velut, J Brotchi, M Levivier: Neuroprotective gene therapy for Parkinson's Disease. Current Gene Therapy 2, 451-483 (2002)
63. Coune PG, B Schneider, P Aebischer: Parkinson's Disease: Gene therapies. Cold Spring Harbor Perspectives in Medicine 2(4) a009431. Doi: 10.1101/cshperspect.a009431.Accessed at www.ncbi.nlm.nih.gov/pmc/articles/ pmc3312404 (2012)